|
|
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2955-2962.
Prepublished online as a Blood First Edition Paper on December 14, 2004; DOI 10.1182/blood-2004-07-2520.
Previous Article | Table of Contents | Next Article 
PHAGOCYTES
Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells
Dorothee Viemann,
Anke Strey,
Annette Janning,
Kerstin Jurk,
Kerstin Klimmek,
Thomas Vogl,
Keiichi Hirono,
Fukiko Ichida,
Dirk Foell,
Beate Kehrel,
Volker Gerke,
Clemens Sorg, and
Johannes Roth
From the Institute of Experimental Dermatology, the Institute of Medical Biochemistry/Center for Molecular Biology of Inflammation, Integrated Functional Genomics, and the Interdisciplinary Clinical Research Center, University of Muenster; the Department of Pediatrics and the Department of Anaesthesiology and Intensive Care, Experimental and Clinical Haemostasis, University Hospital Muenster, Germany; and the Department of Pediatrics, Toyama Medical and Pharmaceutical University, Japan.
Myeloid-related protein 8 (MRP8) and MRP14, S100 proteins secreted by activated phagocytes, bind specifically to endothelial cells. The endothelial response to MRP8/MRP14, however, is unknown. Using oligonucleotide microarray analysis, we show for the first time that MRP8/MRP14 induce a thrombogenic, inflammatory response in human microvascular endothelial cells by increasing the transcription of proinflammatory chemokines and adhesion molecules and by decreasing the expression of cell junction proteins and molecules involved in monolayer integrity. All changes on the gene expression level could be confirmed using biochemical and functional assays. We demonstrated that the expression of MRP8/MRP14 closely correlated with the inflammatory activity in systemic vasculitis, confirming the important role of these proteins for distinct inflammatory reactions in endothelia. MRP8/MRP14 may represent novel targets for anti-inflammatory strategies.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. L. Cecil and R. Terkeltaub
Transamidation by Transglutaminase 2 Transforms S100A11 Calgranulin into a Procatabolic Cytokine for Chondrocytes
J. Immunol.,
June 15, 2008;
180(12):
8378 - 8385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Raquil, N. Anceriz, P. Rouleau, and P. A. Tessier
Blockade of Antimicrobial Proteins S100A8 and S100A9 Inhibits Phagocyte Migration to the Alveoli in Streptococcal Pneumonia
J. Immunol.,
March 1, 2008;
180(5):
3366 - 3374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Johansson, F. Kramer, S. Barnhart, J. E. Kanter, T. Vaisar, R. D. Merrill, L. Geng, K. Oka, L. Chan, A. Chait, et al.
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice
PNAS,
February 12, 2008;
105(6):
2082 - 2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Frosch and J. Roth
New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment
Rheumatology,
February 1, 2008;
47(2):
121 - 125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wittkowski, D. Foell, E. a. Klint, L. D. Rycke, F. D. Keyser, M. Frosch, A.-K. Ulfgren, and J. Roth
Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis
Ann Rheum Dis,
August 1, 2007;
66(8):
1020 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Viemann, K. Barczyk, T. Vogl, U. Fischer, C. Sunderkotter, K. Schulze-Osthoff, and J. Roth
MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program
Blood,
March 15, 2007;
109(6):
2453 - 2460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ehrchen, L. Steinmuller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkotter, and J. Roth
Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes
Blood,
February 1, 2007;
109(3):
1265 - 1274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Foell, H. Wittkowski, T. Vogl, and J. Roth
S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules
J. Leukoc. Biol.,
January 1, 2007;
81(1):
28 - 37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Burns
S100 Proteins in the Pathogenesis of Kawasaki Disease
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1265 - 1267.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hirono, D. Foell, Y. Xing, S. Miyagawa-Tomita, F. Ye, M. Ahlmann, T. Vogl, T. Futatani, C. Rui, X. Yu, et al.
Expression of Myeloid-Related Protein-8 and -14 in Patients With Acute Kawasaki Disease
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1257 - 1264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. McCormick, F. Rahimi, Y. V. Bobryshev, K. Gaus, H. Zreiqat, H. Cai, R. S. A. Lord, and C. L. Geczy
S100A8 and S100A9 in Human Arterial Wall: IMPLICATIONS FOR ATHEROGENESIS
J. Biol. Chem.,
December 16, 2005;
280(50):
41521 - 41529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Foell, J. Roth, J. Abe, H. Saito, and M. Terai
S100 Proteins in Monitoring Inflammation: The Importance of a Gold Standard and a Validated Methodology
J. Immunol.,
September 15, 2005;
175(6):
3459 - 3460.
[Full Text]
[PDF]
|
 |
|
| |